	mitoses_count	sdha	ethnicity	lymph_node_examined_count	excess_adrenal_hormone_history_type	laterality	icd_10	distant_metastasis_anatomic_site	nf1_clinical_diagnosis	tissue_source_site	race	nf1	number_of_lymphnodes_positive_by_he	cytoplasm_presence_less_than_equal_25_percent	new_neoplasm_occurrence_anatomic_site_text	history_of_neoadjuvant_treatment	radiation_therapy	nuclear_grade_III_IV	primary_lymph_node_presentation_assessment	days_to_birth	prior_dx	diffuse_architecture	tmem127	age_at_initial_pathologic_diagnosis	person_neoplasm_cancer_status	new_tumor_event_after_initial_treatment	therapeutic_mitotane_lvl_recurrence	tissue_prospective_collection_indicator	sdhaf2_sdh5	excess_adrenal_hormone_diagnosis_method_type	tissue_retrospective_collection_indicator	gender	histological_type	days_to_death	pathologic_T	gleason_score	additional_pharmaceutical_therapy	new_neoplasm_event_occurrence_anatomic_site	necrosis	ct_scan	bcr_patient_uuid	clinical_N	mitotane_therapy	therapeutic_mitotane_lvl_macroscopic_residual	histologic_disease_progression_present_indicator	extranodal_involvement	icd_o_3_histology	invasion_of_tumor_capsule	psa_value	vhl	sinusoid_invasion	max	residual_tumor	mitotane_therapy_adjuvant_setting	therapeutic_mitotane_levels_achieved	weiss_score	days_to_initial_pathologic_diagnosis	days_to_new_tumor_event_additional_surgery_procedure	metastatic_neoplasm_confirmed_diagnosis_method_name	year_of_initial_pathologic_diagnosis	pathologic_stage	postoperative_rx_tx	days_to_psa	pathologic_N	new_neoplasm_confirmed_diagnosis_method_name	date_of_form_completion	mitotic_rate	ct_scan_findings	sdhd	therapeutic_mitotane_lvl_progression	primary_therapy_outcome_success	secondary_pattern	days_to_new_tumor_event_after_initial_treatment	clinical_M	clinical_T	vital_status	tumor_tissue_site	informed_consent_verified	sdhc	new_neoplasm_event_type	new_tumor_event_additional_surgery_procedure	metastatic_neoplasm_confirmed_diagnosis_method_text	icd_o_3_site	post_surgical_procedure_assessment_thyroid_gland_carcinoma_status	b_symptoms	metastatic_neoplasm_initial_diagnosis_anatomic_site	patient_id	clinical_stage	days_to_last_followup	ret	sdhb	additional_radiation_therapy	mitotane_therapy_for_macroscopic_residual_disease	tertiary_pattern	molecular_analysis_performed_indicator	system_version	primary_pattern	weiss_venous_invasion	pathologic_M	atypical_mitotic_figures
9d1619f3-e482-4090-a645-dcfbe420580e_miR_gene_expression																																																																																																				
d3b6ab10-20aa-41ed-af74-fbe5f1beedc4_miR_gene_expression																																																																																																				
b81decf4-add7-431c-957b-22c4dbd91901_miR_gene_expression																																																																																																				
30996bd8-68c5-4527-99cd-e635057c4574_miR_gene_expression																																																																																																				
a9da33f2-d770-48ed-ab88-a32d3af87122_miR_gene_expression																																																																																																				
3962cb8c-0e7f-4f9b-93f0-623fa0496b54_miR_gene_expression																																																																																																				
6a8f9385-2064-4d8c-9af1-d2bed53afebb_miR_gene_expression	1	[Not Available]	[Not Evaluated]	[Not Available]	None	Right	C74.0	[Not Available]	[Not Available]	OR	WHITE	[Not Available]	[Not Available]	Cytoplasm presence <= 25% Present	[Not Applicable]	No	NO	Nuclear Grade III or IV Present	NO	-8177	No	Diffuse Architecture Present	[Not Available]	22	TUMOR FREE	NO	[Not Available]	NO	[Not Available]	[Not Available]	YES	MALE	Adrenocortical carcinoma- Usual Type	[Not Applicable]	T1	[Not Applicable]	[Not Available]	[Not Available]	Necrosis Absent	YES	B7ADB786-1F81-43CA-AC72-7243966CD439	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Applicable]	8370/3	Invasion of Tumor Capsule Absent	[Not Applicable]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	R0	[Not Available]	[Not Available]	[Not Available]	0	[Not Available]	[Not Available]	2008	Stage I	NO	[Not Applicable]	N0	[Not Available]	2013-9-18	Mitotic Rate > 5/50 HPF Absent	Normal	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	M0	[Not Applicable]	Alive	Adrenal	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	C74.0	No imaging evidence of disease	[Not Applicable]	[Not Available]	A5JI	[Not Applicable]	1423	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	[Not Applicable]	[Not Applicable]	Venous Invasion Absent	[Not Applicable]	Atypical Mitotic Figures Absent
c7af4731-45fe-4988-90c0-6dab28d1b1b9_miR_gene_expression																																																																																																				
290f101e-ff47-4aeb-ad71-11cb6e6b9dde_miR_gene_expression																																																																																																				
b7d7e6c6-257e-4933-b840-5638078556ce_miR_gene_expression																																																																																																				
0aab0660-f928-4ee0-86fb-583e0f3f42d2_miR_gene_expression																																																																																																				
172062d1-53dd-48d1-95a6-353d2079c244_miR_gene_expression																																																																																																				
acf45482-bab9-4eb8-b1fe-3a3c2a4b2572_miR_gene_expression																																																																																																				
23bf15e8-5062-4323-9015-55d7bca67746_miR_gene_expression																																																																																																				
7bf3993e-37c1-4cae-a05c-9a637bb74189_miR_gene_expression																																																																																																				
2bcf51e8-f8f1-4e39-b5b3-a3b5a31fbb51_miR_gene_expression																																																																																																				
0d211146-47bf-4662-b817-a1d8090d0425_miR_gene_expression																																																																																																				
fb2f8a06-1842-4a18-8938-79d54370ce01_miR_gene_expression																																																																																																				
ba6341a4-b64c-4944-9031-1d2a38f39492_miR_gene_expression																																																																																																				
e1c7b750-a19e-4d93-9d1f-259fe446d87d_miR_gene_expression																																																																																																				
6329209a-cd8e-42ef-bddf-fa06e85331d1_miR_gene_expression																																																																																																				
ce867cae-e385-40f0-9861-c70e4ab04b98_miR_gene_expression																																																																																																				
4f810a7e-ec11-4def-9ffe-b8fd8b195943_miR_gene_expression																																																																																																				
47130771-6e2d-49b9-959e-9d62de1acd53_miR_gene_expression																																																																																																				
7036891e-20e6-44ad-ad5f-41a8b1abe747_miR_gene_expression																																																																																																				
3d7b8e16-b5b6-4168-9c9c-c3e0384d837d_miR_gene_expression																																																																																																				
c4dcc3f2-65f2-47fd-9a92-9ac0b07cfb1e_miR_gene_expression																																																																																																				
a66c34f7-2b5a-472b-92d8-f8aeba1a1f2f_miR_gene_expression																																																																																																				
8ca595dc-e9c9-4931-a697-9e781086f7a8_miR_gene_expression																																																																																																				
3db46049-e447-40a2-8e2a-f8befda0961f_miR_gene_expression																																																																																																				
25a9fd1a-0ff1-434b-bc4b-b78834750994_miR_gene_expression	24	[Not Available]	[Not Evaluated]	[Not Available]	Estrogen	Left	C74.0	[Not Available]	[Not Available]	OR	WHITE	[Not Available]	[Not Available]	Cytoplasm presence <= 25% Present	[Not Applicable]	No	[Unknown]	Nuclear Grade III or IV Present	NO	-13862	No	Diffuse Architecture Present	[Not Available]	37	[Unknown]	[Unknown]	[Not Available]	NO	[Not Available]	Biochemical Assessment	YES	MALE	Adrenocortical carcinoma- Usual Type	1750	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	Necrosis Present	[Unknown]	BDFCD747-F6A2-42E2-BC9B-483112205FA8	[Not Applicable]	[Unknown]	[Not Available]	[Not Available]	[Not Applicable]	8370/3	Invasion of Tumor Capsule Absent	[Not Applicable]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	0	[Not Available]	[Not Available]	2001	[Not Available]	[Unknown]	[Not Applicable]	[Not Available]	[Not Available]	2013-9-17	Mitotic Rate > 5/50 HPF Present	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Applicable]	Dead	Adrenal	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	C74.0	[Not Available]	[Not Applicable]	[Not Available]	A5JC	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	[Not Applicable]	[Not Applicable]	Venous Invasion Present	[Not Applicable]	Atypical Mitotic Figures Present
66a354fe-454e-40a6-8464-a7d97236d398_miR_gene_expression	[Not Available]	[Not Available]	[Not Evaluated]	[Not Available]	None	Left	C74.0	[Not Available]	[Not Available]	OR	WHITE	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	No	NO	Nuclear Grade III or IV Absent	NO	-16603	No	Diffuse Architecture Absent	[Not Available]	45	TUMOR FREE	NO	[Not Available]	NO	[Not Available]	[Not Available]	YES	MALE	Adrenocortical carcinoma- Usual Type	[Not Applicable]	T1	[Not Applicable]	[Not Available]	[Not Available]	Necrosis Absent	YES	A19104D6-B6A6-4878-AF2C-783679070A05	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Applicable]	8370/3	Invasion of Tumor Capsule Present	[Not Applicable]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	R0	[Not Available]	[Not Available]	[Not Available]	0	[Not Available]	[Not Available]	2002	Stage I	NO	[Not Applicable]	N0	[Not Available]	2013-9-9	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Complete Remission/Response	[Not Applicable]	[Not Available]	M0	[Not Applicable]	Alive	Adrenal	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	C74.0	No imaging evidence of disease	[Not Applicable]	[Not Available]	A5JR	[Not Applicable]	3688	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	[Not Applicable]	[Not Applicable]	Venous Invasion Absent	[Not Applicable]	[Not Available]
2409f255-8f3e-4376-8ebf-cbbbefbb2361_miR_gene_expression																																																																																																				
4fde6436-41e9-4bd0-bd7c-bf0b63e310fa_miR_gene_expression																																																																																																				
e52fbca3-b617-4b11-ae63-bc22bbd91c64_miR_gene_expression																																																																																																				
c472a9f1-ce1c-4650-b73a-7cbcedddeb4f_miR_gene_expression																																																																																																				
4c661ac0-c043-4f57-8d95-03b46b43ef21_miR_gene_expression																																																																																																				
e6247159-01e1-40d2-a2bb-804b7d8f8ca9_miR_gene_expression																																																																																																				
5f63ecf2-3931-4e84-bef2-412c050a4174_miR_gene_expression																																																																																																				
b5a63033-f14b-4040-b2b2-8acf9c9ba6d4_miR_gene_expression	90	[Not Available]	[Not Evaluated]	[Not Available]	Cortisol	Left	C74.0	[Not Available]	[Not Available]	OR	WHITE	[Not Available]	[Not Available]	Cytoplasm presence <= 25% Present	[Not Applicable]	Yes	YES	Nuclear Grade III or IV Present	[Unknown]	-9359	No	Diffuse Architecture Present	[Not Available]	25	WITH TUMOR	YES	[Not Available]	NO	[Not Available]	Both Clinical and Biochemical Assessments	YES	FEMALE	Adrenocortical carcinoma- Usual Type	549	T4	[Not Applicable]	YES	Liver	Necrosis Present	YES	FB54458D-C373-46C2-841E-82663E13EFAA	[Not Applicable]	YES	[Not Available]	[Unknown]	[Not Applicable]	8370/3	Invasion of Tumor Capsule Present	[Not Applicable]	[Not Available]	Sinusoid Invasion Present	[Not Available]	R1	YES	[Unknown]	[Not Available]	0	[Not Available]	Other, specify	2011	Stage IV	YES	[Not Applicable]	N0	Imaging	2013-10-3	Mitotic Rate > 5/50 HPF Present	Liver Involvement	[Not Available]	[Not Available]	Progressive Disease	[Not Applicable]	71	M1	[Not Applicable]	Dead	Adrenal	YES	[Not Available]	Distant Metastasis	NO	[Not Available]	C74.0	Biochemical Evidence of Disease	[Not Applicable]	Liver	A5JM	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Unknown]	[Not Available]	[Not Applicable]	NO	[Not Applicable]	[Not Applicable]	Venous Invasion Present	[Not Applicable]	Atypical Mitotic Figures Present
c8945d4b-96a0-4ea3-9e70-1d128735b13e_miR_gene_expression																																																																																																				
aa8ea41f-9e25-41d1-afe0-cb9024718957_miR_gene_expression																																																																																																				
ccc7b691-8f4f-46e5-85a4-a02e7f8351c1_miR_gene_expression																																																																																																				
d8fa5d94-672c-4ed6-9c9d-3700ea2c1397_miR_gene_expression																																																																																																				
6486c23b-eebc-4f1d-9864-15b0fc409e3f_miR_gene_expression																																																																																																				
afef1098-9b00-4aa2-b141-23c0a6643e88_miR_gene_expression																																																																																																				
1e1ae4dd-1f89-42bd-8154-165f603962b9_miR_gene_expression	[Not Available]	[Not Evaluated]	NOT HISPANIC OR LATINO	3	None	Left	C74.0	[Not Available]	[Not Evaluated]	OU	WHITE	[Not Evaluated]	3	Cytoplasm presence <= 25% Absent	[Not Applicable]	No	NO	Nuclear Grade III or IV Absent	YES	-19491	No	Diffuse Architecture Absent	[Not Evaluated]	53	WITH TUMOR	YES	[Not Available]	NO	[Not Evaluated]	[Not Available]	YES	FEMALE	Adrenocortical carcinoma- Usual Type	[Not Applicable]	T2	[Not Applicable]	YES	Lung	Necrosis Present	YES	A5BE4E42-CB6C-4E67-8547-45DBD058BB95	[Not Applicable]	YES	[Not Available]	NO	[Not Applicable]	8370/3	Invasion of Tumor Capsule Present	[Not Applicable]	[Not Evaluated]	Sinusoid Invasion Absent	[Not Evaluated]	[Not Available]	YES	[Unknown]	[Not Available]	0	384	Other, specify	2011	Stage IV	YES	[Not Applicable]	N1	Imaging	2013-7-16	Mitotic Rate > 5/50 HPF Absent	Lung Involvement	[Not Evaluated]	[Not Available]	Stable Disease	[Not Applicable]	351	M1	[Not Applicable]	Alive	Adrenal	YES	[Not Evaluated]	Distant Metastasis	YES	Resection	C74.0	Persistent distant metastases	[Not Applicable]	Lung	A5PI	[Not Applicable]	709	RET Negative	[Not Evaluated]	YES	NO	[Not Applicable]	YES	[Not Applicable]	[Not Applicable]	Venous Invasion Absent	[Not Applicable]	Atypical Mitotic Figures Absent
981ec7dd-d76b-49f0-9e74-b923fa7ebe1f_miR_gene_expression																																																																																																				
cb87c1b0-e6c8-44fe-963a-31773ace6181_miR_gene_expression																																																																																																				
b3794e62-c4bc-43b1-97ca-b6f6e01aa026_miR_gene_expression	7	[Not Available]	NOT HISPANIC OR LATINO	[Not Available]	Cortisol	Left	C74.0	[Not Available]	[Not Available]	OR	WHITE	[Not Available]	[Not Available]	Cytoplasm presence <= 25% Present	[Not Applicable]|[Not Applicable]	No	NO	Nuclear Grade III or IV Present	NO	-20656	No	Diffuse Architecture Absent	[Not Available]	56	WITH TUMOR	YES	NO	YES	[Not Available]	Both Clinical and Biochemical Assessments	NO	FEMALE	Adrenocortical carcinoma- Usual Type	[Not Applicable]	T2	[Not Applicable]	NO|NO	Peritoneal Surfaces|Liver	Necrosis Present	YES	28153E3E-8515-4852-AAA0-247F86399F27	[Not Applicable]	YES	YES	YES|YES	[Not Applicable]	8370/3	Invasion of Tumor Capsule Absent	[Not Applicable]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	R0	NO	NO	[Not Available]	0	972|972	[Not Available]	2010	Stage II	NO	[Not Applicable]	N0	Imaging|Imaging	2013-10-8	Mitotic Rate > 5/50 HPF Present	Normal	[Not Available]	YES	Complete Remission/Response	[Not Applicable]	391|391	M0	[Not Applicable]	Alive	Adrenal	YES	[Not Available]	Locoregional Recurrence|Distant Metastasis	YES|YES	[Not Available]	C74.0	No imaging evidence of disease	[Not Applicable]	[Not Available]	A5K6	[Not Applicable]	1130	[Not Available]	[Not Available]	NO|NO	YES	[Not Applicable]	[Unknown]	[Not Applicable]	[Not Applicable]	Venous Invasion Absent	[Not Applicable]	Atypical Mitotic Figures Present
2c3bef15-669a-4fb0-9c07-b3ef5d7b57fc_miR_gene_expression																																																																																																				
8df42e9b-192b-4348-af21-24fa631adc98_miR_gene_expression																																																																																																				
54eb7022-b75b-4989-b701-329b2926814a_miR_gene_expression																																																																																																				
0c10d522-46a0-487f-a35c-9c1afd2a7c96_miR_gene_expression																																																																																																				
440608f5-5a2f-4cf6-bc06-0c8e1c2ec100_miR_gene_expression																																																																																																				
7f5ff6b6-a509-4d17-ba1d-f4852fe8aee4_miR_gene_expression	2	[Not Available]	[Not Evaluated]	[Not Available]	None	Right	C74.0	[Not Available]	[Not Available]	OR	WHITE	[Not Available]	[Not Available]	Cytoplasm presence <= 25% Absent	[Not Applicable]	No	NO	Nuclear Grade III or IV Present	NO	-9546	No	Diffuse Architecture Present	[Not Available]	26	TUMOR FREE	NO	[Not Available]	NO	[Not Available]	[Not Available]	YES	FEMALE	Adrenocortical carcinoma- Usual Type	[Not Applicable]	T1	[Not Applicable]	[Not Available]	[Not Available]	Necrosis Absent	YES	4FBBBE43-3C0E-4475-BCF8-3745BD7195EB	[Not Applicable]	NO	[Not Available]	[Not Available]	[Not Applicable]	8370/3	Invasion of Tumor Capsule Absent	[Not Applicable]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	R0	[Not Available]	[Not Available]	[Not Available]	0	[Not Available]	[Not Available]	2005	Stage I	NO	[Not Applicable]	N0	[Not Available]	2013-9-18	Mitotic Rate > 5/50 HPF Absent	Normal	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	M0	[Not Applicable]	Alive	Adrenal	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	C74.0	No imaging evidence of disease	[Not Applicable]	[Not Available]	A5JO	[Not Applicable]	889	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	[Not Applicable]	[Not Applicable]	Venous Invasion Present	[Not Applicable]	Atypical Mitotic Figures Absent
56ac4bcc-479a-4560-b605-d4906e0768e5_miR_gene_expression																																																																																																				
f97acdec-621e-43e5-9536-39b2657c70c8_miR_gene_expression																																																																																																				
16da7452-fed2-4010-8548-58e70acd6c5a_miR_gene_expression																																																																																																				
c986ab6f-912a-424f-9957-ff34452339c5_miR_gene_expression	[Not Available]	[Not Available]	[Not Evaluated]	[Not Available]	Androgen|Cortisol	Right	C74.0	[Not Available]	[Not Available]	OR	WHITE	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable]	No	NO	[Not Available]	NO	-22596	No	[Not Available]	[Not Available]	61	WITH TUMOR	YES	[Not Available]	NO	[Not Available]	Both Clinical and Biochemical Assessments	YES	FEMALE	Adrenocortical carcinoma- Usual Type	344	T2	[Not Applicable]	[Unknown]|[Unknown]|[Unknown]|[Unknown]	Peritoneal Surfaces|Lymph Node(s)|Lung|Liver	[Not Available]	YES	D890CBF7-41D8-4992-99C2-24C60C77B156	[Not Applicable]	YES	[Not Available]	[Not Available]|[Not Available]|[Not Available]|[Not Available]	[Not Applicable]	8370/3	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	R0	YES	[Unknown]	[Not Available]	0	[Not Available]|[Not Available]|[Not Available]|[Not Available]	[Not Available]	2002	Stage II	NO	[Not Applicable]	N0	Imaging|Imaging|Imaging|Imaging	2013-9-11	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	236|236|236|236	M0	[Not Applicable]	Dead	Adrenal	YES	[Not Available]	Locoregional Recurrence|Locoregional Recurrence|Distant Metastasis|Distant Metastasis	[Unknown]|[Unknown]|[Unknown]|[Unknown]	[Not Available]	C74.0	No imaging evidence of disease	[Not Applicable]	[Not Available]	A5K9	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Unknown]|[Unknown]|[Unknown]|[Unknown]	[Not Available]	[Not Applicable]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Applicable]	[Not Available]
832c14fd-3856-4de0-ae3b-d1489bea83c1_miR_gene_expression																																																																																																				
89ffedc0-67eb-4f69-943e-1562f59c4951_miR_gene_expression																																																																																																				
c0d609c0-049d-4d1a-b991-a212208cff71_miR_gene_expression																																																																																																				
aef89c64-e3e7-46ee-978c-e069e3f9234d_miR_gene_expression																																																																																																				
e7ce147a-90f6-49f5-a389-42557a595412_miR_gene_expression																																																																																																				
677a063a-1c28-4515-b197-783367317f1e_miR_gene_expression																																																																																																				
a33692d5-e688-498c-bb3f-8c22cf38d7a0_miR_gene_expression																																																																																																				
817f3909-75b0-4479-9ae2-797192483ff4_miR_gene_expression																																																																																																				
fbaac44c-1483-40ba-bfdb-26a73c9cbe36_miR_gene_expression																																																																																																				
e4fe4b0b-198a-46b2-adb3-2f0b140502f8_miR_gene_expression	15	[Not Available]	[Not Evaluated]	[Not Available]	None	Right	C74.0	brain	[Not Available]	OR	WHITE	[Not Available]	[Not Available]	Cytoplasm presence <= 25% Present	[Not Applicable]	No	[Unknown]	Nuclear Grade III or IV Present	[Unknown]	-19172	No	Diffuse Architecture Present	[Not Available]	52	[Unknown]	[Unknown]	[Not Available]	NO	[Not Available]	[Not Available]	YES	MALE	Adrenocortical carcinoma- Usual Type	550	T4	[Not Applicable]	[Not Available]	[Not Available]	Necrosis Present	[Unknown]	D63F2F1E-1970-445F-907B-23CF4D9EFD83	[Not Applicable]	[Unknown]	[Not Available]	[Not Available]	[Not Applicable]	8370/3	Invasion of Tumor Capsule Present	[Not Applicable]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	R1	[Not Available]	[Not Available]	[Not Available]	0	[Not Available]	Other, specify	2000	Stage IV	[Unknown]	[Not Applicable]	N0	[Not Available]	2013-9-17	Mitotic Rate > 5/50 HPF Present	[Not Available]	[Not Available]	[Not Available]	[Unknown]	[Not Applicable]	[Not Available]	M1	[Not Applicable]	Dead	Adrenal	YES	[Not Available]	[Not Available]	[Not Available]	excision of brain met 2/28/2000	C74.0	Persistent distant metastases	[Not Applicable]	Other, specify	A5JB	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	NO	[Not Applicable]	[Not Applicable]	Venous Invasion Absent	[Not Applicable]	Atypical Mitotic Figures Present
9635a2c4-fd8b-4b4c-9338-def32b6dd8d3_miR_gene_expression	50	[Not Available]	[Not Evaluated]	6	None	Left	C74.0	[Not Available]	[Not Available]	OR	WHITE	[Not Available]	6	Cytoplasm presence <= 25% Present	[Not Applicable]	No	NO	Nuclear Grade III or IV Present	YES	-24082	No	Diffuse Architecture Present	[Not Available]	65	WITH TUMOR	[Unknown]	[Not Available]	NO	[Not Available]	[Not Available]	YES	MALE	Adrenocortical carcinoma- Usual Type	[Not Applicable]	T4	[Not Applicable]	[Not Available]	[Not Available]	Necrosis Present	YES	9EC86C06-E7A9-4EA6-B36D-6F832909054B	[Not Applicable]	YES	[Not Available]	[Not Available]	[Not Applicable]	8370/3	Invasion of Tumor Capsule Present	[Not Applicable]	[Not Available]	Sinusoid Invasion Present	[Not Available]	R2	[Unknown]	[Not Available]	[Not Available]	0	[Not Available]	[Not Available]	2009	Stage IV	NO	[Not Applicable]	N1	[Not Available]	2013-10-3	Mitotic Rate > 5/50 HPF Present	Lung Involvement	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	M1	[Not Applicable]	Alive	Adrenal	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	C74.0	Persistent distant metastases	[Not Applicable]	Lung	A5JJ	[Not Applicable]	309	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	YES	[Not Applicable]	[Not Applicable]	Venous Invasion Present	[Not Applicable]	Atypical Mitotic Figures Present
88271ae2-c8e5-489d-a0de-1966c7a68703_miR_gene_expression																																																																																																				
1b949b4b-bb02-48b9-a010-ecc1ff95cebb_miR_gene_expression																																																																																																				
7d1dcf1f-34a7-4cbf-b766-9d01715ffe70_miR_gene_expression																																																																																																				
d1dac84f-3362-4f7d-85ff-445c1fc55aaa_miR_gene_expression																																																																																																				
34520288-5a8e-441a-9e46-d8dcd44d777f_miR_gene_expression																																																																																																				
94216633-5cf1-4640-a284-56bec53850aa_miR_gene_expression																																																																																																				
9dfdfd8c-4902-4ada-9908-162f301218d0_miR_gene_expression																																																																																																				
7f50d25e-d637-4e3d-9d65-a7b24d55e8fb_miR_gene_expression																																																																																																				
9d5a8484-3865-4738-adbb-1a99b0ddb086_miR_gene_expression																																																																																																				
